Nordisk Stock

• Novo Nordisk stock experienced a price decline of 1.51%, trading at $48.89. • The dip occurred despite positive news regarding updated Wegovy labeling, which supports the expanded use of the drug in Singapore. • This movement is significant as it shows the stock price weakening even in the face of regulatory progress and market expansion for its key product.

• Novo Nordisk (NVO) stock rose 0.87% today, trading at $49.69. • Technical indicators, including the RSI at 54.96 and MACD, provide strong buy signals, though the CCI and Awesome Oscillator remain neutral. • The stock's short-term movement is guided by key support at $48.64 and resistance at $49.72.